Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aprepitant Regimen for Chemoradiotherapy-Induced Nausea in HNSCC
NCT03572829Phase 2Completed
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Mar 2018
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aprepitant in chemotherapy-induced nausea and vomiting (CINV), sponsored by Chinese Academy of Medical Sciences. Started Mar 2018; status: completed.
02
Drugs
aprepitant
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT03572829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03572829.